张婧Zhang, Halent

资深顾问律师

香港 + 852.3189.7252

联系：

Share

张婧律师的执业领域集中于公司融资和商业交易。张律师曾经参与众多项目并积累了丰富的经验，包括首次公开发行、公众公司和私人公司并购、跨境投资、合资企业、配售、公开招股、二级市场大宗交易、债券发行以及其他一般公司和商业法律服务事宜。张律师亦向上市公司就法律规管及合规事宜提供咨询。

张律师参与的知名案例包括：在浙商银行17亿美元的首次公开发行中为承销商提供咨询；在君实生物4.5亿港元的首次公开发行中为发行人提供咨询；为富士康4.6亿港元收购一家在香港上市的信息技术公司提供咨询；以及为汉德资本成立12亿美元基金和下游投资提供咨询。

张律师在加入众达前曾向上市公司就以20亿港币收购乌龙茶制造商及发行4.91亿人民币的可换股债券提供咨询。

经验

  • Affiliate of Centre Lane Partners acquires appliance business from Instant BrandsJones Day advised an affiliate of Centre Lane Partners in the acquisition and financing of the appliances business of Instant Brands, designer and distributor of kitchen and home appliances, including the Instant Pot, pursuant to Section 363 of title 11 of the United States Code.
  • Junshi grants exclusive rights to Dr. Reddy's for toripalimab cancer treatmentJones Day represented Shanghai Junshi Biosciences Co., Ltd. ("Junshi") in its grant of exclusive rights related to the development and commercialization of toripalimab, an anti-PD1 monoclonal antibody, to Dr. Reddy's Laboratories for the territory of Latin America, India, South Africa, and an option to expand the territory to include Australia and New Zealand and potential other countries.
  • Gaw Capital Partners acquires Florentia Village Guangzhou Outlet MallJones Day advised Gaw Capital Partners in connection with the acquisition by a fund under Gaw’s management, alongside additional coinvestment partners, of Florentia Village Guangzhou, a designer outlet mall in Guangdong, China.
  • Junshi Biosciences forms joint venture with Rxilient Biotech to develop and commercialize toripalimab in Southeast AsiaJones Day advised Junshi Biosciences in the formation of a joint venture company, Excellmab, with Rxilient Biotech to develop and commercialize toripalimab, an anti-PD-1 monoclonal antibody drug, in nine Southeast Asian countries.
  • Vida Capital Partners and Ludhill Limited sell Furrion Holdings to Lippert Components, Inc.Jones Day advised Vida Capital Partners and its affiliates in the disposal of their interests in Furrion Holdings, a leading distributor of high-end appliances to original equipment manufacturers and aftermarket customers in the recreational vehicle, specialty vehicle, and marine industries, to Lippert Components, Inc.
  • AGIC Capital closes $1.2 billion fund for investments in smart industriesJones Day acted as fund formation counsel to AGIC Capital for its $1.2 billion final closing of its second fund, AGIC Fund II L.P., which will be focused on advanced industrial and medical technology investments.
  • Shanghai Junshi Biosciences completes $329 million placing of new H Shares on main board of The Stock Exchange of Hong Kong LimitedJones Day advised Shanghai Junshi Biosciences Co., Ltd. (the “Company”), a company listed on the main board of The Stock Exchange of Hong Kong Limited and the STAR Market of the Shanghai Stock Exchange, in connection with its US$329 million placing of new H Shares of the Company.
  • Junshi and Lilly to develop and commercialize antibodies for prevention and treatment of COVID-19 coronavirusJones Day represented Shanghai Junshi Biosciences Co., Ltd. in its strategic collaboration and license agreement with Eli Lilly and Company for the development, manufacturing, and commercialization of two antibodies for the prevention and treatment of the COVID-19 SARS-CoV-2 novel coronavirus.
  • Cleveland-Cliffs completes offers to exchange 6.375% Senior Notes and 7.00% Senior Notes issued by AK Steel CorporationJones Day represented Cleveland-Cliffs Inc. (“Cliffs”), a large vertically integrated producer of differentiated iron ore and steel in North America, in connection with its offers to exchange any and all 6.375% Senior Notes due 2025 and 7.00% Senior Notes due 2027 issued by AK Steel Corporation for the same aggregate principal amount of new notes issued by Cliffs’.
  • Cleveland-Cliffs issues $725 million of 6.75% Senior Secured NotesJones Day represented Cleveland-Cliffs Inc. ("Cliffs"), a large vertically integrated producer of differentiated iron ore and steel in North America, in connection with an offering of $725 million aggregate principal amount of 6.75% Senior Secured Notes due 2026.
  • CLSA Capital, CLSA, CCB International Capital, and China Galaxy complete approximate $210 million IPO on The Stock Exchange of Hong Kong Limited by Luzhou BankJones Day acted as counsel for the sole sponsor, CLSA Capital Markets Limited, and underwriters, comprising of CLSA Limited, CCB International Capital Limited, China Galaxy International Securities (Hong Kong) Co., Limited, and others, in connection with the $210 million initial public offering of H shares on The Stock Exchange of Hong Kong Limited by Luzhou Bank Co., Ltd. and concurrent Regulation S offering.
  • Shanghai Junshi Biosciences completes $450 million IPO on The Stock Exchange of Hong Kong LimitedJones Day acted as Hong Kong and U.S. counsel for Shanghai Junshi Biosciences Co., Ltd. in connection with its over $450 million initial public offering on The Stock Exchange of Hong Kong Limited and concurrent Rule 144A and Regulation S offerings.
  • Midas acquires Microlife CorporationJones Day advised Midas Fund LP, a joint venture partner in Midas Company Limited, in the acquisition by Midas Company of all of the issued and outstanding shares of Microlife Corporation by way of a 100 percent share swap, for the aggregate consideration of NT$9.3 billion (US$300.9 million).
  • AGIC Capital sells minority stake in CNCE Global Holdings (Hong Kong) Co., LimitedJones Day advised Asia-Germany Industrial Promotion Limited ("AGIC Capital"), an Asian-European private equity investor focused on industrial technology companies in the European and North American mid-market, in connection with its sale of minority stake in CNCE Global Holdings (Hong Kong) Co., Limited.
  • Hyster-Yale acquires 75% of Zhejiang Maximal Forklift TruckJones Day advised Hyster-Yale Materials Handling, Inc. in its acquisition of 75% of the outstanding shares of, and a controlling interest in, Zhejiang Maximal Forklift Company Limited from KNSN Pipe and Pile Company Limited.
  • Halcyon Capital, BOCI Asia, Hong Kong Asset Management, and Halcyon Securities complete IPO on Main Board of Hong Kong Stock Exchange of Precision Tsugami (China) Corporation LimitedJones Day advised Halcyon Capital Limited, as sole sponsor, and BOCI Asia, Hong Kong Asset Management, and Halcyon Securities, as underwriters, in connection with the initial public offering and listing on the Main Board of the Hong Kong Stock Exchange (HKSE) of Precision Tsugami (China) Corporation Limited, an established CNC high precision machine tool manufacturer in China.
  • Cardinal Health acquires leading patient product portfolio from Medtronic for $6.1 billionJones Day advised Cardinal Health on the acquisition of Medtronic's Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency businesses for $6.1 billion in cash.
  • Evergreen Products Group completes IPO and lists on Hong Kong Stock ExchangeJones Day advised Evergreen Products Group in its initial public offering and listing on the Hong Kong Stock Exchange.
  • Automated Systems Holdings completes acquisition of Grid Dynamics International for up to US$118 million funded by rights issue and placing of convertible bondsJones Day advised Automated Systems Holdings Limited, an information technology and software company, in connection with its acquisition of Grid Dynamics International, Inc., a provider of open, scalable, next-generation e-commerce technology solutions, by way of merger at a consideration of up to US$118 million and its financing by way of a HK$193 million rights issue and placing of convertible bonds with an aggregate value of HK$350 million.
  • Foxconn obtains majority acquisition of Teleeye Holdings LimitedJones Day advised Foxconn (Far East Limited) in its acquisition of a 50.07 percent interest in Teleeye Holdings Limited and subsequent mandatory unconditional cash offer to acquire all of the remaining shares.
    •

    January 2024 Commentary

    Hong Kong GEM Listing Reforms Take Effect

    2024年1月 法律评论

    香港创业板上市改革生效

    December 2023 Alert

    Hong Kong Stock Exchange Implements Reforms to Relax IPO "Double Dipping" Restrictions

    2023年12月 法律快讯

    香港联交所实施改革放宽首次公开招股“双重参与”限制

    September 2023 Commentary

    Amendments to the Hong Kong Codes on Takeovers and Mergers and Share Buybacks

    2023年9月 法律评论

    有关香港《公司收购、合并及股份回购守则》的修订

    August 2023 Alert

    Consultation Conclusions on Proposed Amendments to Enforcement-Related Provisions of Hong Kong's SFO

    2023年8月 法律快讯

    有关建议修订香港《证券及期货条例》内与执法相关的条文的咨询总结

    August 2023 Commentary

    Consultation Paper on the Hong Kong Securities and Futures Commission's Proposed Amendments to the Takeovers Codes

    2023年8月 法律评论

    香港证券及期货事务监察委员会发表有关建议修订《公司收购、合并及股份回购守则》的咨询文件
    查看全部观点

    发送前请注意

    *Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice